A major advance in cancer investigation is occurring with the use of nanobodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in various forms of tumors, causing https://travialist.com/story12400152/nanobodies-reactivate-tumor-suppressor-p53-new-new-hope-for-cancer-management